Search

Your search keyword '"Natalya Danchenko"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Natalya Danchenko" Remove constraint Author: "Natalya Danchenko" Topic psychiatry Remove constraint Topic: psychiatry
27 results on '"Natalya Danchenko"'

Search Results

1. Cost-utility evaluation of vortioxetine in patients with Major Depressive Disorder experiencing inadequate response to alternative antidepressants in the United Kingdom

2. The impact of antidepressant treatments on family functioning in adults with major depressive disorder: a post hoc comparison of vortioxetine and agomelatine

3. Comparative evaluation of vortioxetine as a switch therapy in patients with major depressive disorder

4. Patient-centered assessment of cognitive symptoms of depression

5. Cost-utility analysis of vortioxetine versus agomelatine, bupropion SR, sertraline and venlafaxine XR after treatment switch in major depressive disorder in Finland

6. Cost-Utility of Vortioxetine in the Treatment of Major Depressive Disorder: Comparison with Agomelatine, Bupropion, Sertraline and Venlafaxine in the Finnish Setting

7. Symptoms of Anxiety and Irritability in Patients with Major Depressive Disorder

8. Assessing Patient and Caregiver Experiences with Symptoms and Behaviors Associated with Schizophrenia

9. The Use and Performance of Productivity Scales to Evaluate Presenteeism in Mood Disorders

10. Cost-Effectiveness Evaluation in Sweden of Escitalopram Compared with Venlafaxine Extended-Release as First-Line Treatment in Major Depressive Disorder

11. Development of a family functioning scale for major depressive disorder

12. Cost effectiveness analysis of escitalopram compared to venlafaxine and fluvoxamine in treatment of major depressive disorder

13. Escitalopram and Duloxetine in Major Depressive Disorder: A Pharmacoeconomic Comparison Using UK Cost Data

14. The effect of vortioxetine on overall patient functioning in patients with major depressive disorder

15. The effect of vortioxetine (LU AA21004) on health-related quality of life (HRQOL) in patients with major depressive disorder (MDD)

17. Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden

18. PMH60 A PHARMACOECONOMIC COMPARISON OF ESCITALOPRAM AND DULOXETINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) IN THE UNITED KINGDOM

19. The Effect of Vortioxetine on Health-related Quality of Life in Patients With Major Depressive Disorder

20. P.2.f.005 Vortioxetine effects on overall patient functioning in patients with major depressive disorder

22. Psychometric Validation of Perceived Deficits Questionnaire – Depression (PDQ-D) in Patients with Major Depressive Disorder (MDD)

23. Assessing health-related quality of life (HRQOL) in major depressive disorder (MDD): Do commonly used instruments meet EMA requirements for psychometric properties and content relevance

24. PMH24 ECONOMIC BENEFITS OF ESCITALOPRAM VERSUS DULOXETINE IN SPAIN

25. PMH25 COST-EFFECTIVENESS OF ESCITALOPRAM VERSUS VENLAFAXINE IN SECOND-LINE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) IN SWEDEN

26. PMH26 IMPROVED WORK PRODUCTIVITY IN THE UNITED STATES (US) FOR PATIENTS TREATED WITH ESCITALOPRAM COMPARED TO DULOXETINE

Catalog

Books, media, physical & digital resources